首页> 美国卫生研究院文献>PLoS Clinical Trials >Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers
【2h】

Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers

机译:铂类辅助化疗治疗切除的非小细胞肺癌患者巢蛋白表达的预后意义;巢蛋白表达与上皮间质转化相关标志物之间的关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionAlthough adjuvant platinum-based chemotherapy (AC) has been shown to improve survival of patients with completely resected stage II and stage IIIA non-small cell lung cancer (NSCLC), its effect is limited. Nestin is a class VI intermediate filament protein expressed in neural stem cells and several cancer cells including NSCLC. In the present study, we aimed to determine its prognostic significance concerning survival in NSCLC patients receiving AC.
机译:引言尽管已经证明铂类辅助化疗(AC)可以改善完全切除的II期和IIIA期非小细胞肺癌(NSCLC)患者的生存率,但其效果有限。 Nestin是在神经干细胞和包括NSCLC在内的几种癌细胞中表达的VI类中间丝蛋白。在本研究中,我们旨在确定其与接受AC的NSCLC患者生存有关的预后意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号